News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Jones Cecilia
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
09/28/2023 |
4
| Jones Cecilia (CFO) has filed a Form 4 on AGIOS PHARMACEUTICALS, INC.
Txns:
| Sold 2,179 shares
@ $24.79, valued at
$54k
Exercised 7,472 restricted stock units
@ $0 |
|
06/30/2023 |
4
| Jones Cecilia (CFO) has filed a Form 4 on AGIOS PHARMACEUTICALS, INC.
Txns:
| Sold 1,597 shares
@ $28.36, valued at
$45.3k
Exercised 5,380 options to buy
@ $0 |
|
09/28/2022 |
4
| Jones Cecilia (CFO) has filed a Form 4 on AGIOS PHARMACEUTICALS, INC.
Txns:
| Granted 118,390 options to buy
@ $27.88, valued at
$3.3M
Granted 22,417 restricted stock units
@ $0 |
|
09/28/2022 |
3
| Jones Cecilia (CFO) has filed a Form 3 on AGIOS PHARMACEUTICALS, INC. |
03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/13/2022 |
4
| Jones Cecilia (CFO) has filed a Form 4 on LogicBio Therapeutics, Inc.
Txns:
| Paid exercise price by delivering 2,175 shares
@ $2.01, valued at
$4.4k
Exercised 5,939 restricted stock units
@ $0 |
|
02/25/2021 |
4
| Jones Cecilia (CFO) has filed a Form 4 on LogicBio Therapeutics, Inc.
Txns:
| Granted 78,000 options to buy
@ $7.76, valued at
$605.3k
|
|
01/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/13/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|